Market Research Logo

Serbia Pharmaceuticals and Healthcare Report Q2 2016

Serbia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The Serbian pharmaceutical and healthcare market remains one of the least attractive within the CEE region for foreign drugmakers. Government cost containment, implemented through severe drug price cuts by the RFZO, will dampen growth. Furthermore, an increasing reliance on private health spending will impact pharmaceutical sales as the worsening macroeconomic outlook will reduce consumer spending power. Headline Expenditure Projections Pharmaceuticals: RSD91.42bn (USD840mn) in 2015 to RSD87.40bn (USD762mn) in 2016; -4.4% in local currency terms and -9.3% in US dollar terms. Forecast unchanged from Q116. Healthcare: RSD372.29bn (USD3.42bn) in 2015 to RSD362.75bn (USD3.15bn) in 2016; -2.6% in local currency terms and -7.6% in US dollar terms. Forecast unchanged from Q116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Serbia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Serbia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Serbia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Serbia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Serbia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Serbia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Serbia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Serbia 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Serbia Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Environment
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Serbia 2010-2015)
Table: Healthcare Personnel (Serbia 2010-2015)
Table: Healthcare Activity (Serbia 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Company Profile
Hemofarm (Stada)
Galenika
Demographic Forecast
Table: Population Headline Indicators (Serbia 2005-2025)
Table: Population By Age Group (Serbia 2005-2025)
Table: Population By Age Group % (Serbia 2005-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report